PMC:7161517 / 21936-22163 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T130","span":{"begin":96,"end":102},"obj":"Body_part"},{"id":"T131","span":{"begin":103,"end":112},"obj":"Body_part"}],"attributes":[{"id":"A130","pred":"fma_id","subj":"T130","obj":"http://purl.org/sig/ont/fma/fma62970"},{"id":"A131","pred":"fma_id","subj":"T131","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"Treatment with rhACE2 showed improved cardiac output that coincided with maximum suppression of plasma cytokines and reduction in nitrotyrosine levels, improved peripheral vascular resistance, and improved renal perfusion (58)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T219","span":{"begin":96,"end":102},"obj":"http://purl.obolibrary.org/obo/UBERON_0001969"}],"text":"Treatment with rhACE2 showed improved cardiac output that coincided with maximum suppression of plasma cytokines and reduction in nitrotyrosine levels, improved peripheral vascular resistance, and improved renal perfusion (58)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T267","span":{"begin":130,"end":143},"obj":"Chemical"}],"attributes":[{"id":"A267","pred":"chebi_id","subj":"T267","obj":"http://purl.obolibrary.org/obo/CHEBI_86267"}],"text":"Treatment with rhACE2 showed improved cardiac output that coincided with maximum suppression of plasma cytokines and reduction in nitrotyrosine levels, improved peripheral vascular resistance, and improved renal perfusion (58)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T138","span":{"begin":0,"end":227},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Treatment with rhACE2 showed improved cardiac output that coincided with maximum suppression of plasma cytokines and reduction in nitrotyrosine levels, improved peripheral vascular resistance, and improved renal perfusion (58)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T762","span":{"begin":38,"end":45},"obj":"UBERON:0000948"},{"id":"T763","span":{"begin":96,"end":102},"obj":"UBERON:0001969"},{"id":"T764","span":{"begin":130,"end":143},"obj":"CHEBI:86267;CHEBI:86267"},{"id":"T765","span":{"begin":206,"end":211},"obj":"UBERON:0002113"},{"id":"T79570","span":{"begin":31,"end":41},"obj":"UBERON:0002349"},{"id":"T17295","span":{"begin":59,"end":66},"obj":"UBERON:0000948"},{"id":"T7913","span":{"begin":75,"end":91},"obj":"UBERON:0004535"},{"id":"T31024","span":{"begin":111,"end":117},"obj":"UBERON:0000479"},{"id":"T80939","span":{"begin":166,"end":170},"obj":"G_3;PG_10;PR:000003622"},{"id":"T64668","span":{"begin":171,"end":175},"obj":"PR:000036013"}],"text":"Treatment with rhACE2 showed improved cardiac output that coincided with maximum suppression of plasma cytokines and reduction in nitrotyrosine levels, improved peripheral vascular resistance, and improved renal perfusion (58)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"953","span":{"begin":15,"end":21},"obj":"Chemical"},{"id":"954","span":{"begin":130,"end":143},"obj":"Chemical"}],"attributes":[{"id":"A954","pred":"tao:has_database_id","subj":"954","obj":"MESH:C002744"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Treatment with rhACE2 showed improved cardiac output that coincided with maximum suppression of plasma cytokines and reduction in nitrotyrosine levels, improved peripheral vascular resistance, and improved renal perfusion (58)."}

{"project":"2_test","denotations":[{"id":"32305401-29903860-55252980","span":{"begin":223,"end":225},"obj":"29903860"}],"text":"Treatment with rhACE2 showed improved cardiac output that coincided with maximum suppression of plasma cytokines and reduction in nitrotyrosine levels, improved peripheral vascular resistance, and improved renal perfusion (58)."}